(3-Bromopropyl)benzene → HCID 24995141, compound
Reaction equation
[CH3:1][C:2]([C:4]1[C:9]([OH:10])=[C:8]([O:11][CH3:12])[C:7]2[O:13][CH:14]=[CH:15][C:6]=2[C:5]=1[O:16][CH3:17])=[O:3].[C:18]1([CH2:24][CH2:25][CH2:26]Br)[CH:23]=[CH:22][CH:21]=[CH:20][CH:19]=1>>[C:2]([C:4]1[C:9]([O:10][CH2:26][CH2:25][CH2:24][C:18]2[CH:23]=[CH:22][CH:21]=[CH:20][CH:19]=2)=[C:8]([O:11][CH3:12])[C:7]2[O:13][CH:14]=[CH:15][C:6]=2[C:5]=1[O:16][CH3:17])(=[O:3])[CH3:1]Participants
3
Procedure
Khellinone (59 mg, 0.25 mmol) and 3-(phenyl)propylbromide (46 μL, 0.30 mmol) were treated as described under General Procedure A to afford the title compound (76 mg, 85%) as a colourless solid: 1H NMR (300 MHz, CDCl3): δ 2.03 (m, 2H), 2.53 (s, 3H), 2.76 (t, J=7.8 Hz, 2H), 3.97 (s, 3H), 4.03 (s, 3H), 4.08 (t, J=6.3 Hz, 2H), 6.86 (d, J=2.4 Hz, 1H), 7.14-7.30 (m, 5H), 7.56 (d, J=2.4 Hz, 1H). MS (ES+) m/z 355.1 (M+H+).
Sources & evidence
- ORD record
- ord-3de7d757449c4b01a07ebd2f7cbe1de9
- Source dataset
- uspto-grants-2012_11
- Patent number
- US08309545B2
Reaction notes
Loading…